Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 The developmental origins of health and disease: an overview
- 2 The ‘developmental origins’ hypothesis: epidemiology
- 3 The conceptual basis for the developmental origins of health and disease
- 4 The periconceptional and embryonic period
- 5 Epigenetic mechanisms
- 6 A mitochondrial component of developmental programming
- 7 Role of exposure to environmental chemicals in developmental origins of health and disease
- 8 Maternal nutrition and fetal growth and development
- 9 Placental mechanisms and developmental origins of health and disease
- 10 Control of fetal metabolism: relevance to developmental origins of health and disease
- 11 Lipid metabolism: relevance to developmental origins of health and disease
- 12 Prenatal hypoxia: relevance to developmental origins of health and disease
- 13 The fetal hypothalamic–pituitary–adrenal axis: relevance to developmental origins of health and disease
- 14 Perinatal influences on the endocrine and metabolic axes during childhood
- 15 Patterns of growth: relevance to developmental origins of health and disease
- 16 The developmental environment and the endocrine pancreas
- 17 The developmental environment and insulin resistance
- 18 The developmental environment and the development of obesity
- 19 The developmental environment and its role in the metabolic syndrome
- 20 Programming the cardiovascular system
- 21 The role of vascular dysfunction in developmental origins of health and disease: evidence from human and animal studies
- 22 The developmental environment and atherogenesis
- 23 The developmental environment, renal function and disease
- 24 The developmental environment: effect on fluid and electrolyte homeostasis
- 25 The developmental environment: effects on lung structure and function
- 26 Developmental origins of asthma and related allergic disorders
- 27 The developmental environment: influences on subsequent cognitive function and behaviour
- 28 The developmental environment and the origins of neurological disorders
- 29 The developmental environment: clinical perspectives on effects on the musculoskeletal system
- 30 The developmental environment: experimental perspectives on skeletal development
- 31 The developmental environment and the early origins of cancer
- 32 The developmental environment: implications for ageing and life span
- 33 Developmental origins of health and disease: implications for primary intervention for cardiovascular and metabolic disease
- 34 Developmental origins of health and disease: public-health perspectives
- 35 Developmental origins of health and disease: implications for developing countries
- 36 Developmental origins of health and disease: ethical and social considerations
- 37 Past obstacles and future promise
- Index
- References
5 - Epigenetic mechanisms
Published online by Cambridge University Press: 08 August 2009
Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 The developmental origins of health and disease: an overview
- 2 The ‘developmental origins’ hypothesis: epidemiology
- 3 The conceptual basis for the developmental origins of health and disease
- 4 The periconceptional and embryonic period
- 5 Epigenetic mechanisms
- 6 A mitochondrial component of developmental programming
- 7 Role of exposure to environmental chemicals in developmental origins of health and disease
- 8 Maternal nutrition and fetal growth and development
- 9 Placental mechanisms and developmental origins of health and disease
- 10 Control of fetal metabolism: relevance to developmental origins of health and disease
- 11 Lipid metabolism: relevance to developmental origins of health and disease
- 12 Prenatal hypoxia: relevance to developmental origins of health and disease
- 13 The fetal hypothalamic–pituitary–adrenal axis: relevance to developmental origins of health and disease
- 14 Perinatal influences on the endocrine and metabolic axes during childhood
- 15 Patterns of growth: relevance to developmental origins of health and disease
- 16 The developmental environment and the endocrine pancreas
- 17 The developmental environment and insulin resistance
- 18 The developmental environment and the development of obesity
- 19 The developmental environment and its role in the metabolic syndrome
- 20 Programming the cardiovascular system
- 21 The role of vascular dysfunction in developmental origins of health and disease: evidence from human and animal studies
- 22 The developmental environment and atherogenesis
- 23 The developmental environment, renal function and disease
- 24 The developmental environment: effect on fluid and electrolyte homeostasis
- 25 The developmental environment: effects on lung structure and function
- 26 Developmental origins of asthma and related allergic disorders
- 27 The developmental environment: influences on subsequent cognitive function and behaviour
- 28 The developmental environment and the origins of neurological disorders
- 29 The developmental environment: clinical perspectives on effects on the musculoskeletal system
- 30 The developmental environment: experimental perspectives on skeletal development
- 31 The developmental environment and the early origins of cancer
- 32 The developmental environment: implications for ageing and life span
- 33 Developmental origins of health and disease: implications for primary intervention for cardiovascular and metabolic disease
- 34 Developmental origins of health and disease: public-health perspectives
- 35 Developmental origins of health and disease: implications for developing countries
- 36 Developmental origins of health and disease: ethical and social considerations
- 37 Past obstacles and future promise
- Index
- References
Summary
Introduction
There is a growing awareness that whether or not a gene is actively expressed within a particular cell is determined not only by the primary nucleotide sequence of the gene and its regulatory elements, but also by changes in the way the DNA is modified and packaged within the nucleus. This non-sequence-based information is termed epigenetic. Epigenetic changes include methylation of the DNA itself, and modifications of the histone proteins that package the DNA within chromosomes. The pattern of epigenetic information varies from cell type to cell type and is reflected by the cell-specific profile of gene expression. Once established in a differentiated cell type, these epigenetic signals are stably inherited through mitosis, and are essential to maintain the correct gene expression profile within cells of that type for the life of the organism. The acquisition and maintenance of the correct epigenetic profile is therefore essential for normal development. The past decade has witnessed an explosion in our understanding of so-called ‘epigenetic diseases’, where the disruption of an epigenetic signal results in the inappropriate expression or silencing of one or more genes, giving rise to the disease phenotype. The aims of this chapter are to introduce the chemical nature of the major epigenetic signals, to discuss epigenetic processes which take place during normal development, and to briefly review some of the important examples of human diseases arising due to breakdowns in epigenetic processes.
- Type
- Chapter
- Information
- Developmental Origins of Health and Disease , pp. 62 - 74Publisher: Cambridge University PressPrint publication year: 2006
References
, , , , and (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23, 185–8.CrossRefGoogle ScholarPubMed
, , et al. (2003). Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell, 3, 89–95.CrossRefGoogle ScholarPubMed
and (2001). Methyl-CpG-binding proteins: targeting specific gene repression. Eur. J. Biochem., 268, 1–6.CrossRefGoogle ScholarPubMed
, and (1996). Differential underacetylation of histones H2A, H3 and H4 on the inactive X chromosome in human female cells. Hum. Genet., 97, 573–8.CrossRefGoogle ScholarPubMed
, , , , and (2002). Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes. Nat. Genet., 30, 73–6.CrossRefGoogle ScholarPubMed
, and (2002). Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J. Nutr., 132, 2393S–400S.CrossRefGoogle ScholarPubMed
, , et al. (2000). Epigenotype–phenotype correlations in Beckwith–Wiedemann syndrome. J. Med. Genet., 37, 921–6.CrossRefGoogle ScholarPubMed
, , et al. (1983). The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res., 11, 6883–94.CrossRefGoogle ScholarPubMed
and (2000). Molecular-clinical spectrum of the ATR-X syndrome. Am. J. Med. Genet., 97, 204–12.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
, , , and (2001). Relationship between DNA methylation, histone H4 acetylation and gene expression in the mouse imprinted Igf2–H19 domain. FEBS Lett., 488, 165–9.CrossRefGoogle ScholarPubMed
, , , and (1989). Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet., 83, 155–8.CrossRefGoogle ScholarPubMed
, , et al. (2002). Epigenetic reprogramming in mouse primordial germ cells. Mech. Dev., 117, 15–23.CrossRefGoogle ScholarPubMed
, and (2004). Linking the epigenetic ‘language’ of covalent histone modifications to cancer. Br. J. Cancer, 90, 761–9.CrossRefGoogle Scholar
, , , , and (2000). CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature, 405, 486–9.CrossRefGoogle ScholarPubMed
, , and (2002). Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development, 129, 1983–93.Google ScholarPubMed
and (1975). DNA modification mechanisms and gene activity during development. Science, 187, 226–32.CrossRefGoogle ScholarPubMed
, , , and (1993). Studies of the DNA binding properties of histone H4 amino terminus: thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 ‘tail’ to DNA. J. Biol. Chem., 268, 305–14.Google Scholar
, and (2003). Chromatin remodeling and human disease. Curr. Opin. Genet. Dev., 13, 246–52.CrossRefGoogle ScholarPubMed
, , et al. (2004). Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies. Blood, 103, 1635–40.CrossRefGoogle Scholar
, , et al. (2004). Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature, 429, 900–3.CrossRefGoogle Scholar
, , et al. (2001). Aberrant methylation of donor genome in cloned bovine embryos. Nat. Genet., 28, 173–7.CrossRefGoogle ScholarPubMed
, , et al. (2003). Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. Clin. Cancer. Res., 9, 3578–88.Google ScholarPubMed
, , et al. (2004). Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev., 18, 1592–1605.CrossRefGoogle Scholar
(1971). Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68, 820–3.CrossRefGoogle ScholarPubMed
and (2002). The many faces of histone lysine methylation. Curr. Opin. Cell. Biol., 14, 286–98.CrossRefGoogle ScholarPubMed
, and (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69, 915–26.CrossRefGoogle ScholarPubMed
and (2003). Chromatin remodeling by ATP-dependent molecular machines. Bioessays, 25, 1192–1200.CrossRefGoogle ScholarPubMed
, , , , and (2003). Disruption of imprinted gene methylation and expression in cloned preimplantation stage mouse embryos. Biol. Reprod., 69, 902–14.CrossRefGoogle ScholarPubMed
, , et al. (1999). Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. Proc. Natl. Acad. Sci. USA, 96, 13983–8.CrossRefGoogle ScholarPubMed
and (1984). Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell, 37, 179–83.CrossRefGoogle ScholarPubMed
(2001). Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu. Rev. Neurosci., 24, 1161–92.CrossRefGoogle Scholar
, and (1987). Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development, 99, 371–82.Google ScholarPubMed
, , and (1999). Epigenetic inheritance at the agouti locus in the mouse. Nat. Genet., 23, 314–18.CrossRefGoogle ScholarPubMed
and (1998). A catalogue of imprinted genes and parent-of-origin effects in humans and animals. Hum. Mol. Genet., 7, 1599–1609.CrossRefGoogle ScholarPubMed
, , et al. (2001). Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein–Taybi syndrome. Hum. Mol. Genet., 10, 1071–6.CrossRefGoogle ScholarPubMed
, and (2002). Cooperation between complexes that regulate chromatin structure and transcription. Cell, 108, 475–87.CrossRefGoogle ScholarPubMed
, and (1998). Imprinting in Prader–Willi and Angelman syndromes. Trends Genet., 14, 194–200.CrossRefGoogle ScholarPubMed
and (2004). Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet., 20, 214–20.CrossRefGoogle ScholarPubMed
, , et al. (2002). Early death of mice cloned from somatic cells. Nat. Genet., 30, 253–4.CrossRefGoogle ScholarPubMed
, , and (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99, 247–57.CrossRefGoogle Scholar
, , et al. (2000). Active demethylation of the paternal genome in the mouse zygote. Curr. Biol., 10, 475–8.CrossRefGoogle ScholarPubMed
, , et al. (2003). Role of histone H3 lysine 27 methylation in X inactivation. Science, 300, 131–5.CrossRefGoogle ScholarPubMed
, , and (1999). Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation. J. Biol. Chem., 274, 33002–10.CrossRefGoogle ScholarPubMed
, , and (1999). Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet. Cytogenet., 109, 34–9.CrossRefGoogle ScholarPubMed
, , , and (2002). Metastable epialleles in mammals. Trends Genet., 18, 348–51.CrossRefGoogle ScholarPubMed
, , , , and (2003). Human cloning: can it be made safe? Nat. Rev. Genet., 4, 855–64.CrossRefGoogle ScholarPubMed
and (2004). The SWI/SNF complex: chromatin and cancer. Nat. Rev. Cancer, 4, 133–42.CrossRefGoogle ScholarPubMed
, , , , and (2000). X inactivation in the mouse embryo deficient for Dnmt1: distinct effect of hypomethylation on imprinted and random X inactivation. Dev. Biol., 225, 294–303.CrossRefGoogle ScholarPubMed
, , and (2002). Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev. Biol., 241, 172–82.CrossRefGoogle ScholarPubMed
, , et al. (2003). Epigenetic marking correlates with developmental potential in cloned bovine preimplantation embryos. Curr. Biol., 13, 1116–21.CrossRefGoogle ScholarPubMed
, , et al. (2002). Active genes are tri-methylated at K4 of histone H3. Nature, 419, 407–11.CrossRefGoogle ScholarPubMed
, , et al. (1999). Requirement of Rsk-2 for epidermal growth factor- activated phosphorylation of histone H3. Science, 285, 886–91.CrossRefGoogle ScholarPubMed
, , and (2003). Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells. Leuk. Res., 27, 437–44.CrossRefGoogle ScholarPubMed
and (2003). Histone sumoylation is associated with transcriptional repression. Proc. Natl. Acad. Sci. USA, 100, 13225–30.CrossRefGoogle ScholarPubMed
, , et al. (2003). Establishment of histone h3 methylation on the inactive X chromosome requires transient recruitment of Eed–Enx1 polycomb group complexes. Dev. Cell, 4, 481–95.CrossRefGoogle ScholarPubMed
and (2000). The language of covalent histone modifications. Nature, 403, 41–5.CrossRefGoogle ScholarPubMed
, , et al. (2002). Cloned mice have an obese phenotype not transmitted to their offspring. Nat. Med., 8, 262–7.CrossRefGoogle Scholar
, and (1998). Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev., 12, 3693–702.CrossRefGoogle ScholarPubMed
, and (2002). X chromosome inactivation: how human are mice? Cytogenet. Genome Res., 99, 30–5.CrossRefGoogle ScholarPubMed
and (1999). Cytosine methylation and mammalian development. Genes Dev., 13, 26–34.CrossRefGoogle ScholarPubMed
and (2003). Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol., 23, 5293–5300.CrossRefGoogle ScholarPubMed
, , et al. (2004). Epigenetic programming by maternal behavior. Nat. Neurosci., 7, 847–54.CrossRefGoogle ScholarPubMed
, , and (1998). Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. Faseb. J., 12, 949–57.CrossRefGoogle ScholarPubMed
, , , , and (2002). In vitro production and nuclear transfer affect dosage compensation of the X-linked gene transcripts G6PD, PGK, and Xist in preimplantation bovine embryos. Biol. Reprod., 66, 127–34.CrossRefGoogle ScholarPubMed
, , et al. (1999). Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature, 402, 187–91.CrossRefGoogle Scholar
, , et al. (2003). The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc. Natl. Acad. Sci. USA, 100, 10635–40.CrossRefGoogle ScholarPubMed
, and (1997). Cytosine methylation and the ecology of intragenomic parasites. Trends Genet., 13, 335–40.CrossRefGoogle ScholarPubMed
(2003). Transcriptional regulation by histone ubiquitination and deubiquitination. Genes Dev., 17, 2733–40.CrossRefGoogle ScholarPubMed
- 6
- Cited by